Dr. Daniel S. Olsson, MSc, MD, PhD, is a Global Development Medical Director at AstraZeneca in Gothenburg, Sweden, and an Associate Professor of Endocrinology at The Institution of Medicine, University of Gothenburg, Sweden. He graduated from medical school at University of Gothenburg in 2010 and he completed a Research Internship at Sahlgrenska University Hospital in 2012. During 2013, he was the Head of Studies for Interns at Sahlgrenska University Hospital. He defended his thesis in 2014, which was entitled “Non-functioning pituitary tumors – mortality, morbidity and tumor progression.”
Between 2019 and 2021, he was the Assistant Head of PhD Studies at The Institution of Medicine at University of Gothenburg and oversaw the PhD students with clinical projects. After completing a Research Residency at the Department of Endocrinology at Sahlgrenska University Hospital he became a consultant in 2020. In 2021 he joined the Late-Stage R&D (Cardiovascular, Renal and Metabolism) at AstraZeneca, Gothenburg, Sweden. At the University of Gothenburg he is actively conducting clinical research in the field mortality/morbidity studies in patients with pituitary tumors and translational studies aiming to find biomarkers of aggressiveness in pituitary tumors.
Dr. Olsson is currently serving as a member of the Community of Practice Workgroup, the Steering Group of The Early Career SIG and the Research Affairs Core Committee at The Endocrine Society as well is serving as a member of The Early Career Member Task Force at The European Society of Endocrinology.
Why are you interested in attending ENDO 2022?
The Endocrine Society Annual meeting is the perfect place to gain access to cutting edge scientific and clinical knowledge. It is also a good place to start and foster collaborations with international colleagues.
As a previous ENDO attendee, what is your fondest memory of the annual meeting?
One of many good memories from ENDO Annual meetings was when gave my first oral presentation as a medical student at ENDO 2009 in Washington DC, US.
Would you recommend the ENDO Annual Meeting to a friend or colleague? If so, please explain.
I would recommend the ENDO Annual Meeting to everyone that has an interest in endocrinology.
If you could create an ENDO event, session, or activity, what would it be?
I would like to combine a Meet the Professor session with an oral presentation session. This would enable an expert in the field to set the scene before the presentation of an abstract with cutting edge science.
From your perspective, what are the advantages of a virtual annual meeting?
Of course, nothing can beat the real live experience of being at ENDO, but the possibility of attending this important meeting virtually is allowing people across the globe to attend and gain valuable knowledge during the pandemic.